Ketogenic diet therapy for high-grade gliomas combined with standard treatment using an angiogenesis inhibitor: An exploratory pilot study on feasibility
The combination of mKD and standard therapy with BEV was safe and feasible in patients with malignant glioma. Larger clinical trials are needed to determine its anti-tumor efficacy and clinical benefit.
Authors
- Takashi Sasayama (ORCID: https://orcid.org/0000-0002-5593-9045)
- Satoko Tabuchi
- Shunsuke Yamanishi (ORCID: https://orcid.org/0000-0002-8734-4169)
- Misa Yamanishi
- Michiko Matsunaga (ORCID: https://orcid.org/0000-0002-0316-3839)
- Sayaka Hotta (ORCID: https://orcid.org/0009-0009-7270-8677)
- Yusuke Ikeuchi (ORCID: https://orcid.org/0009-0004-5364-7702)
- K. Tanaka
- Keisuke Hagihara (ORCID: https://orcid.org/0000-0002-6179-0195)
- Shoji Sanada
- Masamitsu Nishihara (ORCID: https://orcid.org/0000-0003-2926-5830)
- Yoshihiro Muragaki
- Hiroaki Nagashima
- Misaki Kuroda
- Yuichi Fujita
- Hirohumi Iwahashi
- Michiko Takahashi
Institutions
- Kobe Medical Center (JP)
- Kobe University Hospital (JP)
- Kobe City Nishi-Kobe Medical Center (JP)
- Kyoto University of Education (JP)
- Kobe University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1093/noajnl/vdaf264
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00